OV101 (gaboxadol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OV101 (gaboxadol), covering 2025-07-18 to 2025-07-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome [Phase 3]